세계의 보조생식기술(ART) 시장 규모, 점유율, 성장 분석 : 유형별, 최종 용도별, 지역별 - 산업 예측(2025-2032년)

Assisted Reproductive Technology Market size was valued at USD 35.92 billion in 2023 and is poised to grow from USD 38.9 billion in 2024 to USD 73.62 billion by 2032, growing at a CAGR of 8.3% during the forecast period (2025-2032).

The global market for Assisted Reproductive Technology (ART) is experiencing significant growth due to rising infertility rates and increased awareness of fertility treatments and surrogacy. ART encompasses a range of methods including in vitro fertilization (IVF) and gestational surrogacy, designed to assist individuals and couples in conceiving. The World Health Organization estimates that in 2020, approximately 48 million couples and 186 million individuals faced infertility diagnoses, emphasizing the scale of the need for these services. Additionally, the Centers for Disease Control and Prevention highlight that 6% to 12% of American women with PCOS also struggle with infertility, further propelling demand. With funding from both public and private sectors and ongoing technological advancements, the ART market's prospects remain robust.

Top-down and bottom-up approaches were used to estimate and validate the size of the Assisted Reproductive Technology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Assisted Reproductive Technology Market Segments Analysis

Global Assisted Reproductive Technology Market is segmented by Type, End-Use and region. Based on Type, the market is segmented into In-Vitro Fertilization (IVF), Artificial Insemination and Others. Based on End-Use, the market is segmented into Fertility Clinics, Hospitals and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Assisted Reproductive Technology Market

The rise in infertility rates, driven by factors like delayed childbirth, lifestyle modifications, and environmental influences, underscores the growing importance of Assisted Reproductive Technology (ART). As more couples seek solutions for their infertility issues, there is a corresponding increase in demand for ART services. This heightened interest not only highlights the need for viable reproductive options but also propels the growth of the ART industry, making it a vital component of modern reproductive health solutions. Consequently, the trend indicates a significant expansion potential for ART, reflecting society's evolving approach to family building in the face of fertility challenges.

Restraints in the Assisted Reproductive Technology Market

One of the primary challenges facing the Assisted Reproductive Technology (ART) market is the high cost associated with treatments such as in vitro fertilization (IVF) and other related procedures. These substantial expenses can limit accessibility and affordability for many patients, ultimately hindering the overall growth of the market, especially in areas that lack robust healthcare infrastructure. As a result, the financial burden can prevent individuals from seeking necessary ART services, thereby stifling market expansion in regions where the demand for such technologies exists but is unmet due to prohibitive costs.

Market Trends of the Assisted Reproductive Technology Market

The Assisted Reproductive Technology (ART) market is witnessing a significant trend towards the expansion of personalized solutions, bolstered by advancements in genetic screening and embryo analysis. This shift towards individualized ART therapies is driven by the desire to enhance overall success rates and optimize treatment efficiency. By addressing specific causes of infertility and tailoring approaches to meet individual patient needs, healthcare providers can offer more targeted and effective fertility treatments. As a result, this trend not only improves patient outcomes but also fosters continued innovation in the reproductive health sector, reflecting an evolving landscape that prioritizes personalized care.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Advancement

Global Assisted Reproductive Technology Market Size by Type & CAGR (2025-2032)

• Market Overview
• In-Vitro Fertilization (IVF)
• Artificial Insemination
• Others

Global Assisted Reproductive Technology Market Size by End-Use & CAGR (2025-2032)

• Market Overview
• Fertility Clinics
• Hospitals
• Others

Global Assisted Reproductive Technology Market Size & CAGR (2025-2032)

• North America (Type, End-Use)
  • US
  • Canada
• Europe (Type, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vitrolife AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperSurgical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Irvine Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring Pharmaceuticals (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genea Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cryolab Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bloom IVF Center (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cosmos Biomedical Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• European Sperm Bank (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parallabs (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microm UK Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Esco Medical (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IVFtech ApS (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Cooper Companies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations